Biochemical profile of patients with spinal and bulbar muscular atrophy
| Mean±SD (range; median) | Reference range | Out of reference range | ||
|---|---|---|---|---|
| High | Low | |||
| Biochemical analyses | ||||
| Haematocrit (%) | 0.43±0.02 (0.37–0.50; 0.43) | 0.41–0.507 | 1/73 | 0/73 |
| Creatine kinase (UI/L) | 1095.8±823 (119–4406; 823) | 20–180 | 68/73 | 0/73 |
| Fasting glucose (nmol/L) | 5.9±1.7 (3.7–14.1; 5.4) | 3.7–5.6 | 29/73 | 0/73 |
| Glycated haemoglobin (nmol/L) | 38.9±8.2 (25–75; 37) | 20–38 | 25/73 | 0/73 |
| Triglycerides (mg/dL) | 1.94±1.26 (0.51–9.28; 1.66) | <2.11 | 35/73 | – |
| Total cholesterol (nmol/L/L) | 5.3±1.0 (3.32–8; 5.33) | <5.18 | 40/73 | – |
| High-density lipoprotein (nmol/L) | 1.42±0.5 (0.32–2.86; 1.34) | >1.55 | – | 50/73 |
| Low-density lipoprotein (nmol/L) | 3.3±0.87 (1.78–4.68; 3.2) | <3.34 | 29/73 | – |
| Prostate-specific antigen (µg/L) | 1.17±1.18 (0.11–21.7; 0.5) | <4 | 3/73 | – |